Physician profile
Hina Azmat
NPI 1154567642
$354.51
in general payments reported to CMS, 2019-2025
7 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.85 · 2022: $82.06 · 2023: $57.81 · 2024: $60.53 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $213 · Education: $34.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $212.84 |
| Education | $34.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $183.20 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Insmed, INC. | $55.17 | 2025 | Brinsupri, Arikayce |
| Abbvie INC. | $49.50 | 2022 | |
| Abbott Laboratories | $20.18 | 2024 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $16.92 | 2025 | Airsupra |
| Novartis Pharmaceuticals Corporation | $14.91 | 2022 | |
| Kyowa Kirin, INC. | $14.63 | 2023 | Crysvita |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hina Azmat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.